Research output per year
Research output per year
Fingerprint
Dive into the research topics where Roger Clarnette is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Balance on the Brain: a randomised controlled trial evaluating the effect of a multimodal exercise programme on physical performance, falls, quality of life and cognition for people with mild cognitive impairment-study protocol
Burton, E., Hill, K., Ellis, K. A., Hill, A-M., Lowry, M., Moorin, R., McVeigh, J. A., Jacques, A., Erickson, K. I., Tate, J., Bernard, S., Orr, C. F., Bongiascia, L., Clarnette, R., Clark, M. L., Williams, S. & Lautenschlager, N., 18 Apr 2022, In: BMJ Open. 12, 4, e054725.Research output: Contribution to journal › Article › peer-review
Open Access -
Early identification of frailty: Developing an international delphi consensus on pre-frailty
Sezgin, D., O'Donovan, M., Woo, J., Bandeen-Roche, K., Liotta, G., Fairhall, N., Rodríguez-Laso, A., Apóstolo, J., Clarnette, R., Holland, C., Roller-Wirnsberger, R., Illario, M., Mañas, L. R., Vollenbroek-Hutten, M., Doğu, B. B., Balci, C., Pernas, F. O., Paul, C., Ahern, E., Romero-Ortuno, R. & 11 others, , 1 Mar 2022, In: Archives of Gerontology and Geriatrics. 99, 104586.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study)
Lam, V., Clarnette, R., Francis, R., Bynevelt, M., Watts, G., Flicker, L., Orr, C. F., Loh, P., Lautenschlager, N., Reid, C. M., Foster, J. K., Dhaliwal, S. S., Robinson, S., Corti, E., Vaccarezza, M., Horgan, B., Takechi, R. & Mamo, J., 21 Feb 2022, In: BMJ Open. 12, 2, p. e058826Research output: Contribution to journal › Article › peer-review
Open Access -
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
the Dominantly Inherited Alzheimer Network–Trials Unit, 21 Jun 2021, In: Nature Medicine. 27, 7, p. 1187-1196 10 p.Research output: Contribution to journal › Article › peer-review
35 Citations (Scopus) -
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies
Su, Y., Flores, S., Wang, G., Hornbeck, R. C., Speidel, B., Joseph-Mathurin, N., Vlassenko, A. G., Gordon, B. A., Koeppe, R. A., Klunk, W. E., Jack, C. R., Farlow, M. R., Salloway, S., Snider, B. J., Berman, S. B., Roberson, E. D., Brosch, J., Jimenez-Velazques, I., van Dyck, C. H., Galasko, D. & 25 others, , 1 Dec 2019, In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 11, p. 180-190 11 p.Research output: Contribution to journal › Article › peer-review
Open Access41 Citations (Scopus)